What is pathophysiology of Breast cancer?

['Faalogologo i lenei itulau']

O le ā le pathophysiology o le kanesa o le susu?

O le pathophysiology o le kanesa o le susu e faasino atu i suiga lē masani i faiga masani o le tino ma auala e tutupu i le atinaʻe ma le alualu i luma o le kanesa o le susu.

E aofia ai le suʻesuʻeina o le auala e tutupu ai sela o le susu ma le auala e sosolo ai sela o le kanesa.

E aofia ai ma vala tau kenera, epigenetic, ma le siʻosiʻomaga e māfua ai le kanesa o le susu.

O nisi o suiga autū o le tino o le tagata i le kanesa o le susu e aofia ai:

1. Fesuiaʻiga o sela o le tino: O suiga i sela o le tino e pei o le BRCA1 ma le BRCA2, e mafai ona faateleina ai le lamatiaga o le maua i le kanesa o le susu.

O nei suiga e mafai ona tuufaasolo mai pe maua mai foʻi a o faagasolo le olaga o se tagata.

2. O le lē paleni o le homone: O homone, aemaise lava le estrogen, e mafai ona aafia ai le tupu aʻe ma le faateleina o le kanesa o le susu.

O le lē paleni o le maualuga o homone po o le tele o le estrogen e mafai ona faateleina ai le lamatiaga o le kanesa o le susu.

3. Fulafula: O le fulafula faaumiumi o sela o le susu e mafai ona māfua ai le kanesa o le susu, ona e faateleina ai sela o le kanesa ma ola ai pea.

4. Vaega o loo siʻomia ai le tuma: O le siʻomaga o loo siʻomia ai le tuma, e aofia ai le vaega o loo i fafo atu o sela, sela e puipuia ai le tino, ma alātoto, e mafai ona aafia ai le tupu aʻe ma le sosolo atu o le kanesa o le susu.

5. Metastasis: O le kanesa o le susu e mafai ona sosolo atu i isi vaega o le tino e ala i le lymphatic system po o le toto, ma oo atu ai i le faia o ni tuma e tutupu i totoga e mamao ese atu.

O le malamalama i le pathophysiology o le kanesa o le susu e tāua tele mo le atinaʻeina o auala e puipuia ai, vave iloa, ma togafitiga.

['Faʻamatalaga']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Underwood SM: Breast cancer in African American women: nursing essentials. ABNF J. , 17 (1): 3-14.

Paliwal SR, Paliwal R, Agrawal GP, Vyas SP: Liposomal nanomedicine for breast cancer therapy. Nanomedicine (Lond). 2011, 6 (6): 1085-100.

Rauch GM, Adrada BE: Comparison of Breast MR Imaging with Molecular Breast Imaging in Breast Cancer Screening, Diagnosis, Staging, and Treatment Response Evaluation. Magn Reson Imaging Clin N Am. 2018, 26 (2): 273-280.

Wei H, Wang H, Ji Q, Sun J, Tao L, Zhou X: NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathway. Onco Targets Ther. 2015, 8 (): 3721-30.

Eden JA: Human breast cancer stem cells and sex hormones--a narrative review. Menopause. 2010, 17 (4): 801-10.

Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM, Richardson A, Sledge GW, Carey LA: Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res. 2008, 14 (24): 8010-8.

['Faamatalaga: faafomaʻi']

['O lenei upega tafaʻilagi ua saunia mo na o le aʻoaʻoina ma le faailoaina atu o faamatalaga, ae e lē o se fautuaga faafomaʻi po o se auaunaga faapolofesa.']

['E lē tatau ona faaaogā faamatalaga o loo maua mai ai e iloa ai po o le ā le maʻi o loo aafia ai, ma e tatau i ē o loo saʻili mo ni fautuaga faafomaʻi, ona talanoa atu i se fomaʻi ua agavaa.']

['Faamolemole ia mātau, o le neural net lea e maua ai tali i fesili, e lē saʻo pe a oo i fuainumera.']

["Ia saʻili i taimi uma le fautuaga a lau fomaʻi poʻo se isi fomaʻi agavaa e tusa ai ma se maʻi. Aua neʻi e le amanaʻia fautuaga faʻapitoa a fomaʻi pe tuai ona saili ona o se mea na e faitauina i luga o lenei upega tafailagi. Afai e te manatu e ono i ai sau faʻalavelave faʻafuaseʻi, valaʻau le 911 pe alu i le potu lata ane faʻafuaseʻi. E leai se fomaʻi-tagata gasegase sootaga e faia e lenei 'upega tafaʻilagi poʻo lona faʻaaogaina. E leai se BioMedLib poʻo ana tagata faigaluega, poʻo se tasi e fesoasoani i lenei' upega tafaʻilagi, faia ni faʻamatalaga, faʻaalia pe faʻaalia, e tusa ai ma faʻamatalaga o loʻo tuʻuina atu iinei poʻo lona faʻaaogaina."]

['Faʻasalaga: puletaofia']

['O le Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (le DMCA) e maua ai le avanoa mo tagata e umia le puletaofia o loʻo talitonu o mea o loʻo aliali mai i luga o le Initaneti e solia ai a latou aia tatau i lalo o le tulafono a le US copyright. ']

['Afai e te talitonu ma le talitonuga lelei e faapea o so o se mataupu po o meafaitino ua maua e fesootai ma lo tatou website po o auaunaga solia lou puletaofia, e mafai ona e (po o lou sooupu) auina atu i tatou se faasilasilaga talosagaina e faapea o le mataupu po o meafaitino e aveesea, po o le avanoa i ai poloka. ']

['E tatau ona auina atu faasilasilaga i se faiga tusitusia e ala i imeli (tagai i le vaega o le "Contact" mo le tuatusi imeli). ']

['O le DMCA e manaʻomia ai lau faʻasilasilaga o le faʻaleagaina o le puletaofia e aofia ai faʻamatalaga nei: (1) faʻamatalaga o le galuega faʻatagaina o loʻo faʻatatau i le faʻaleagaina o le puletaofia; (2) faʻamatalaga o le mea e ono solia ai ma faʻamatalaga lava e faʻatagaina ai matou ona maua le anotusi; (3) faʻamatalaga faʻafesoʻotaʻi mo oe, e aofia ai lau tuatusi, numera telefoni ma tuatusi imeli; (4) o se faʻamatalaga mai ia te oe o loʻo ia te oe le talitonuga lelei o le anotusi i le auala na faitio ai e le faʻatagaina e le pule o le puletaofia, poʻo lana sooupu, poʻo le faʻatinoina o soʻo se tulafono; ']

['(5) o se faamatalaga mai iā te oe, ua sainia i lalo o le faasalaga o le pepelo, e faapea o faamatalaga o loo i le faasilasilaga e saʻo ma e iai lau pule e faamalosia ai le aiā tatau lea o loo faapea mai ua solia; ']

['ma le (6) saini faaletino po o saini faaeletoroni a lē e ana le aiā tatau po o se tagata ua faatagaina e galue e fai ma sui o lē e ana le aiā tatau. ']

['Afai e lē o aofia uma faamatalaga o loo i luga, e ono faatuai ai ona iloilo lau faitioga.']

['Faafesootaʻi']

['Faamolemole lafo mai se imeli i so o se fesili / fautuaga.']

What is pathophysiology of breast cancer?

Pathophysiology of breast cancer refers to the abnormal changes in the normal physiological processes and mechanisms that occur in the development and progression of breast cancer.

It involves the study of the underlying biological and molecular mechanisms that lead to the uncontrolled growth and spread of cancer cells in the breast tissue.

This includes the genetic, epigenetic, and environmental factors that contribute to the initiation, promotion, and progression of breast cancer.

Some of the key pathophysiological changes in breast cancer include:

1. Genetic mutations: Mutations in certain genes, such as BRCA1 and BRCA2, can increase the risk of developing breast cancer.

These mutations can be inherited or acquired during a person's lifetime.

2. Hormonal imbalances: Hormones, particularly estrogen, can play a role in the development and growth of breast cancer.

An imbalance in hormone levels or exposure to excess estrogen can increase the risk of breast cancer.

3. Inflammation: Chronic inflammation in the breast tissue can contribute to the development of breast cancer by promoting the growth and survival of cancer cells.

4. Tumor microenvironment: The environment surrounding the tumor, including the extracellular matrix, immune cells, and blood vessels, can influence the growth and spread of breast cancer.

5. Metastasis: Breast cancer can spread to other parts of the body through the lymphatic system or bloodstream, leading to the formation of secondary tumors in distant organs.

Understanding the pathophysiology of breast cancer is crucial for developing effective prevention, early detection, and treatment strategies.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.